150 related articles for article (PubMed ID: 23537824)
21. Seroepidemiology of varicella-zoster in Pakistan.
Akram DS; Qureshi H; Mahmud A; Khan AA; Kundi Z; Shafi S; N-ur-Rehman ; Olowokure B; Weil J; Bock H; Yazdani I
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):646-9. PubMed ID: 11414405
[TBL] [Abstract][Full Text] [Related]
22. Validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated children, adolescents, and young adults in the post-vaccine licensure era.
Perella D; Fiks AG; Jumaan A; Robinson D; Gargiullo P; Pletcher J; Forke CM; Schmid DS; Renwick M; Mankodi F; Watson B; Spain CV
Pediatrics; 2009 May; 123(5):e820-8. PubMed ID: 19403475
[TBL] [Abstract][Full Text] [Related]
23. Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study.
Vandersmissen G; Moens G; Vranckx R; de Schryver A; Jacques P
Occup Environ Med; 2000 Sep; 57(9):621-6. PubMed ID: 10935943
[TBL] [Abstract][Full Text] [Related]
24. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
26. Varicella seroprevalence in a random sample of the Turkish population.
Kanra G; Tezcan S; Badur S;
Vaccine; 2002 Jan; 20(9-10):1425-8. PubMed ID: 11818162
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt.
Ibrahim EG; Abdel Wahed WY; Eid HM; Deeb WS
J Egypt Public Health Assoc; 2019; 94(1):2. PubMed ID: 30686830
[TBL] [Abstract][Full Text] [Related]
28. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
30. Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.
Mirinaviciute G; Barlinn R; Gjeruldsen Dudman S; Flem E
PLoS One; 2019; 14(8):e0221084. PubMed ID: 31408478
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of antibodies against varicella-zoster virus among prevalent hemodialysis patients.
Talebi-Taher M; Hassanzadeh T; Ossareh S
Iran J Kidney Dis; 2013 Nov; 7(6):475-8. PubMed ID: 24241094
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of varicella zoster virus infections in Colombo district, Sri Lanka.
Liyanage NP; Fernando S; Malavige GN; Mallikahewa R; Sivayogan S; Jiffry MT; Vitarana T
Indian J Med Sci; 2007 Mar; 61(3):128-34. PubMed ID: 17337813
[TBL] [Abstract][Full Text] [Related]
33. A seroepidemiological study of Varicella-Zoster virus in Taipei City.
Lin YJ; Huang LM; Lee CY; Chih TW; Lee PL; Chang LY; Hsu CM
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):11-5. PubMed ID: 8936004
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of New Entrant University students in Sri Lanka to varicella zoster infection.
Kurukulasooriya GM; Thevanesam V; Agampodi SB; Abeykoon AM; Amarasiri SP; Goonasekera KP
Asia Pac J Public Health; 2010 Apr; 22(2):219-24. PubMed ID: 19411280
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of hepatitis A virus and varicella zoster antibodies in a Javanese community (Yogyakarta, Indonesia).
Juffrie M; Graham RR; Tan RI; Widjaja S; Mulyadi S; Weil J; Bock HL
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):21-4. PubMed ID: 11023059
[TBL] [Abstract][Full Text] [Related]
36. Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010).
Cardenas A; Smit E; Houseman EA; Kerkvliet NI; Bethel JW; Kile ML
Environ Health Perspect; 2015 Jun; 123(6):590-6. PubMed ID: 25636148
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis.
Manouchehrinia A; Tanasescu R; Kareem H; Jerca OP; Jabeen F; Shafei R; Breuer J; Neal K; Irving W; Constantinescu CS
J Neurovirol; 2017 Dec; 23(6):839-844. PubMed ID: 28895088
[TBL] [Abstract][Full Text] [Related]
38. Age related seroprevalence of antibodies to varicella in India.
Lokeshwar MR; Agrawal A; Subbarao SD; Chakraborty MS; Ram Prasad AV; Weil J; Bock HL; Kanwal S; Shah RC; Shah N
Indian Pediatr; 2000 Jul; 37(7):714-9. PubMed ID: 10906803
[TBL] [Abstract][Full Text] [Related]
39. [The seroepidemiology of the varicella-zoster virus in children and adolescents].
Gil Miguel A; Lasheras Lozano ML; Jiménez García R; Calle Purón ME; Santos Santos M; Rey Calero J; Martín Hernández D
Aten Primaria; 1993 May; 11(8):416-8. PubMed ID: 8388262
[TBL] [Abstract][Full Text] [Related]
40. A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.
Amjadi O; Rafiei A; Haghshenas M; Navaei RA; Valadan R; Hosseini-Khah Z; Omran AH; Arabi M; Shakib RJ; Mousavi T; Ashrafi GH
J Clin Virol; 2017 Feb; 87():49-59. PubMed ID: 28011413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
